Oh Oh!  Third brain disease case!  Glad I got out of this a few weeks ago (posted within the dow thread with other sells)!  Trader was worried this would happen!

 

 

I don't think it will change anything the FDA does with this drug-again these patients would rather risk the brain disorder vs their disease they are being treated for. bet it still doesn't come off the market-would have to be dozens of cases. 

 

The problem is the BIIB/ELN PPS will take a dump everytime it happens whether it results in anything serious or not.  The entire medicalinvesting world is now too sensitized to this issue and adverse event.

 

ELN has been getting more bad streams of news too.  About a week back their partnership with WYE took a turn for the worse, when the EU asked that their P3 Alzheimer trials be delayed for further review and potential changes as a result of some P2 study results.  These were the studies Trader asked about and I discussed months ago with him and I specifically remembered saying they were rolling these out fast (before other results) and taking liberties with the timeline of the process.  Well now the EU has slapped their fingers here.  They took a calculated risk to save time-THEY LOST!

 

Finally the speciality division of ELN has not been sold yet.  I assume it will, but imagine its delayed because of credit and financial issues currently festering in the world!

 

Tick, tack, toe, three in a row!  Ouch for them!

 

Kutz